Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-treatment predictors of response for assessing outcomes to standard treatment in infection with HCV genotype 3.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP - 1 Feb 2011

Qureshi Saleem, Batool Uzma, Iqbal Mussarat, Burki Umar Farooq, Khan Naqeeb Ullah

Abstract excerpt

OBJECTIVE: To determine the role of pre-treatment predictors of response in assessing outcomes to standard treatment in HCV genotype 3. STUDY DESIGN: Observational study. PLACE AND DURATION OF STUDY: Department of Medicine, KRL General Hospital, Islamabad, from December 2004 to December 2006. METHODOLOGY: All patients with positive anti-HCV and PCR genotype 3a were recruited and written and informed consent was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Logistic Models

Share to Predictive Value of Tests

Share to Ribavirin

Source

Identifiers

PMID: 21333234
DOI: 02.2011/JCPSP.781784

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-treatment predictors of response for assessing outcomes to standard treatment in infection with HCV genotype 3.PMID 21333234Read ↗

Optimum predictors of therapeutic outcome in HCV patients in Pakistan.Semantic proximity Read ↗

A Multi-Biomarker Prediction Model Integrating Genetics, Hematological Indices, and Fibrosis Stage to Forecast Non-Response in HCV Genotype 4Semantic proximity Read ↗

Response rates to standard interferon treatment in HCV genotype 3a.Semantic proximity Read ↗

Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients.Semantic proximity Read ↗

Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.Semantic proximity Read ↗

Predictors of response to antiviral therapy in patients with chronic hepatitis C from Pakistani population.Semantic proximity Read ↗

Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.Semantic proximity Read ↗

Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C.Semantic proximity Read ↗

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.Semantic proximity Read ↗

Predictors of response to chronic hepatitis C treatment.Semantic proximity Read ↗

Infection with hepatitis C virus genotype 3--experience of a tertiary health care centre in south India.Semantic proximity Read ↗

HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.